Hemopericardium in a Sirolimus-Treated Renal Transplant Patient

被引：0
|
作者：
Groudan, Kevin [1 ]
Sawalha, Khalid [2 ]
Bhat, Anusha G. [1 ]
Eltanbedawi, Ahmed [1 ]
Ambesh, Paurush [3 ]
机构：
[1] Baystate Med Ctr, Internal Med, Springfield, MA 01199 USA
[2] Univ Massachusetts, Med Sch Baystate, Internal Med, Springfield, MA USA
[3] Univ Massachusetts, Med Sch Baystate, Cardiovasc Med, Springfield, MA USA
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2020年 / 12卷 / 08期
关键词：
hemopericardium; sirolimus; renal transplant; immunosuppression; LYMPHEDEMA;
D O I：
10.7759/cureus.9508
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Sirolimus is an immunosuppressant frequently prescribed to prevent graft-vs-host disease in renal transplant patients. Pericardial effusion is recognized as a rare and potentially lethal side effect of this medication. Hemopericardium, specifically, is an even rarer complication that has yet to be reported in the literature. We report the first case of sirolimus-induced hemopericardium in a renal transplant patient.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Conversion to Sirolimus in Renal Transplant Recipients: A Single-Center Experience
    Yelken, Berna
    Caliskan, Yasar
    Ozkan, Oktay
    Gorgulu, Numan
    Yazici, Halil
    Turkmen, Aydin
    Sever, Mehmet S.
    ARTIFICIAL ORGANS, 2010, 34 (08) : E230 - E237
  • [32] Proteinuria following conversion from azathioprine to sirolimus in renal transplant recipients
    van den Akker, J. M.
    Wetzels, J. F. M.
    Hoitsma, A. J.
    KIDNEY INTERNATIONAL, 2006, 70 (07) : 1355 - 1357
  • [33] Malignant hypertension in a patient with end of stage renal disease (ESRD) treated by renal transplant
    Giondal, Murtaza
    Farook, Khalid
    Moin, Shaheen
    Bano, Uzma
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2007, 17 (05): : 286 - 288
  • [34] Aggressive Posttransplant Lymphoproliferative Disease in a Renal Transplant Patient Treated With Alemtuzumab
    Muzaffar, Mahvish
    Taj, Asma
    Ratnam, Shobha
    AMERICAN JOURNAL OF THERAPEUTICS, 2010, 17 (06) : E230 - E233
  • [35] Transplant-associated Thrombotic Microangiopathy in Pediatric Patients Treated With Sirolimus and Tacrolimus
    Rosenthal, Joseph
    Pawlowska, Anna
    Bolotin, Ellen
    Cervantes, Cheryl
    Maroongroge, Sean
    Thomas, Sandra H.
    Forman, Stephen J.
    PEDIATRIC BLOOD & CANCER, 2011, 57 (01) : 142 - 146
  • [36] Sirolimus interferes with iron homeostasis in renal transplant recipients
    Maiorano, Annamaria
    Stallone, Giovanni
    Schena, Antonio
    Infante, Barbara
    Pontrelli, Paola
    Schena, Francesco Paolo
    Grandaliano, Giuseppe
    TRANSPLANTATION, 2006, 82 (07) : 908 - 912
  • [37] Sirolimus reduces cancer risk after renal transplant
    Reactions Weekly, 2005, 1079 (1) : 5 - 6
  • [38] Testosterone concentrations and Sirolimus in male renal transplant patients
    Fritsche, L
    Budde, K
    Dragun, D
    Einecke, G
    Diekmann, F
    Neumayer, HH
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (01) : 130 - 131
  • [39] Timing of sirolimus conversion influences recovery of renal function in liver transplant recipients
    Rogers, Christin C.
    Johnson, Scott R.
    Mandelbrot, Didier A.
    Pavlakis, Martha
    Horwedel, Timothy
    Karp, Seth J.
    Egbuna, Ogo
    Rodrigue, James R.
    Chudzinski, Robyn E.
    Goldfarb-Rumyantzev, Alexander S.
    Hanto, Douglas W.
    Curry, Michael P.
    CLINICAL TRANSPLANTATION, 2009, 23 (06) : 887 - 896
  • [40] Sirolimus for visceral and cutaneous Kaposi's sarcoma in a renal-transplant recipient
    Gheith O.
    Bakr A.
    Wafa E.
    Fouda A.
    El Agroudy A.
    Refaie A.
    Donia A.
    Sabry A.
    Sobh M.
    Shokeir A.
    Ghoneim M.
    Clinical and Experimental Nephrology, 2007, 11 (3) : 251 - 254
12345